Atherosclerosis and Lipoproteins |
From the Department of Cardiology (T.J.R., J.F.B. III, A.v.d.L., A.V.G.B.), the Department of Medical Statistics (A.H.Z.), and the Department of Pathology (S.G.v.D.), Leiden University Medical Center, Leiden, the Netherlands; the Laboratory for Intensive Care Research and Optical Spectroscopy (T.J.R., J.F.B. III, G.J.P.), Institute of General Surgery, Erasmus University Rotterdam and University Hospital Rotterdam, Rotterdam, the Netherlands; and the Thoraxcenter of the Erasmus University (A.F.W.v.d.S., N.A.B.), Rotterdam, the Netherlands. Dr Brennan is now at 3M Telecommunications System Divisions, Austin, Tex.
Correspondence to Tjeerd J. Römer, MD, Department of Cardiology, C5-P, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, Netherlands. E-mail romer{at}cardio.azl.nl
| Abstract |
|---|
|
|
|---|
Key Words: coronary arteries atherosclerosis intravascular ultrasound Raman spectroscopy
| Introduction |
|---|
|
|
|---|
Raman spectroscopy is a promising technique that can be used to characterize the chemical composition of biological tissue. A Raman spectrum of a given molecule is unique,11 12 13 14 which makes Raman spectroscopy ideal for detecting, identifying, and diagnosing diseases that involve gross chemical changes in tissue, such as atherosclerosis. Raman spectra can be obtained by processing the collected light that is scattered from an artery as it is illuminated with a laser beam. With sensitive laboratory equipment, quality spectra can be collected in less than a second, and most spectral features are visible in spectra collected in only a few seconds via optical fiber catheters.15 Because Raman spectroscopy is nondestructive, one can collect spectra of the tissue in situ, which can be processed to provide quantitative information about the chemical composition of the arterial wall.16 Previously, it has been demonstrated that the relative weights of the major lipid classes and calcium salts (CS) in homogenized human coronary arterial wall can be calculated with Raman spectra and that estimates of these amounts are correlated closely with those determined by standard lipid assays (±3%) and CS assays (±5%).17 This quantitative chemical information obtained with Raman spectroscopy has been used to identify histopathologically atherosclerotic lesions in vitro.18 In vivo measurements have been hindered by the high background noise generated by light scattering within the optical fibers used to construct intravascular Raman probes. We anticipate that recent technical advances in optical fiber technology will allow adequate reduction of the background signal and the collection of high-quality Raman spectra of the arterial wall in vivo.19 20 21 Once in vivo Raman measurements are made possible during catheterization, one will need a means to identify from where the spectra are collected. IVUS can provide morphological information from the vascular wall. A combination of Raman spectroscopy diagnosis and IVUS technologies, which may be possible with current catheter technology, may produce a powerful diagnostic tool.
In the present in vitro study, we explore the diagnostic capabilities created by combining these techniques. We investigate the value of adding the quantitative chemical information provided by Raman spectroscopy to the information given by IVUS. Future applications of the Raman/IVUS combination may allow the possibility of multidimensional chemical mappings of an arterial wall. This information may be useful in a variety of ways. For instance, the clinician could monitor the effects of lipid-lowering therapies22 and identify lesions that are prone to rupture.
| Methods |
|---|
|
|
|---|
IVUS Images
An IVUS imaging catheter (Visions FX plus, EndoSonics) was used
to collect images at various locations along the segments. This imaging
system is composed of a catheter with acoustic elements mounted
circumferentially around its distal tip and a digital imaging system.
The image, generated perpendicular to the axis of the catheter, has a
slice thickness of
350 to 500 µm. Digital reconstruction of
the acoustic vectors produces an accurate 2D image of a
360o circumferential slice of the
coronary arterial wall at an axial resolution of
80 µm.
During IVUS measurements, calcifications were identified by the shadows behind echo-dense areas on the real-time IVUS images. These arterial planes were marked with a curved surgical needle positioned opposite the calcification, which was clearly visible in the IVUS image. The needle mark served to ensure that the Raman spectroscopic measurements would be obtained from the same axial plane. Digital images of nonatherosclerotic arterial sites and atherosclerotic plaques were stored and analyzed. The arterial segments were then snap-frozen in liquid nitrogen and stored at -80°C until Raman spectroscopic examination. IVUS images were analyzed by 2 experienced investigators, and calcifications were graded after agreement had been reached by these 2 investigators. The Raman spectroscopic measurements were performed off-line on separate occasions to prohibit bias.
Raman Spectroscopic Examination
The arterial segments were thawed, opened
longitudinally, flattened, and positioned on an aluminum sample holder.
Raman spectra were obtained from the luminal side at 0.5-mm intervals
over the entire circumference; intervals were marked by a needle
(Figure 1
).
|
A Raman microspectroscopic system was used for these studies. This
system coupled infrared laser light of 850-nm wavelength from a
titanium/sapphire laser (model 375 B, Spectra Physics) pumped by an
argon-ion laser (model 2020, Spectra Physics) into a microscope by
means of a holographic notch filter (Kaiser Optical Systems). In the
microscope, a 20x objective (PL-FL 20 Nachet) of numerical aperture
0.35 concentrated the laser light onto the sample (Figure 2
). The samples were irradiated with
300-mW laser light in a 25-µm-diameter spot. Scattered light was
collected and collimated by the same objective. Inelastically scattered
light was transmitted by the holographic filter and focused onto the
100-µm core of an optical fiber. This optical fiber led the collected
light to a laboratory-built single-stage F/2 Littrow spectrometer. For
signal detection, a charge-coupled device (CCD) camera
(Princeton Instruments) equipped with a back-illuminated
deep-depletion CCD chip was used. Spectral resolution was
8
cm-1, and signal collection times were 10
seconds. Laser irradiation did not cause visually or spectroscopically
noticeable degradation of the samples. Repeated measurements at the
same location did not result in spectral changes.
|
Raman Spectrum Processing
After background correction,15 the spectra were
modeled as a linear combination of spectra of 7 arterial
components.17 These components were free
cholesterol, cholesterol esters, CS,
triglycerides and phospholipids, 2 delipidized
arterial segments, and ß-carotene.17 The
contribution of some components in the coronary
arterial spectrum, such as triglycerides and
proteins, is difficult to model with spectra obtained from commercially
available chemicals because these components in the artery contain
mixtures of related molecules. Therefore, these components were
extracted from the arterial wall itself. The
triglyceride spectra were obtained from
triglycerides isolated from adventitial fat. The individual
delipidized arterial spectra, which contained mainly signal
contributions from arterial proteins, were obtained from
delipidized arterial samples, one that appeared to be
nonatherosclerotic tissue and another that appeared to be noncalcified
atherosclerotic tissue by visual inspection. The delipidized
arterial spectra were used to model the spectral
contribution of all components of the arterial wall, except
lipids, mineral components, and carotene. By appropriately weighting
the compound spectra used in the fit, we previously showed that it is
possible to determine the relative weights of these compounds to within
a few percent.17 All spectra in the data set in the
present study could be modeled accurately with this spectral
model.
Histology
Several
18-µm-thick frozen sections through the marked
locations from where the IVUS and Raman measurements were taken were
prepared and selectively stained for total cholesterol
(cholesterol and cholesterol esters) by
an enzymatic method based on the production of
H2O2 from
cholesterols by cholesterol
oxidase.23 With this method, peroxide production
is visualized by a brown reaction product formed after peroxidation
of diaminobenzidine by
H2O2. In a number of cases,
the sections were counterstained with hematoxylin to enhance
contrast.
Comparison Between IVUS and Raman Spectroscopy in Detecting
Calcifications
The detection of calcification by IVUS was compared with the
relative amounts of CS as determined by Raman spectroscopy. Each IVUS
image was divided in radial segments, like the pieces of a pie. For
each of the 17 arterial samples, the number of radial
segments was made equal to the number of Raman spectra obtained from
the entire circumference of the arterial lumen. Because
Raman spectra were obtained in 0.5-mm steps, this number of spectra
varied (from 11 to 30); this variation was dependent on the luminal
diameter of the arterial wall. The radial segments of the
IVUS images were analyzed for the presence of a calcification
and separated into a group of radial arterial segments with
calcification (IVUS calcification-positive segments) and a group
without calcification (IVUS calcification-negative segments). The
Raman-determined CS amount for each segment was then compared with the
IVUS classification. In total, 332 radial segments were
analyzed for CS.
| Results |
|---|
|
|
|---|
170°. The artery
was cut open, and a series of 16 Raman spectra was collected from the
luminal side along the entire circumference of the same cross section.
Each of the 16 Raman spectra was processed and fit with the spectra
from the individual chemical components. Figure 3B
|
Cholesterol present in histological
sections of the marked arterial plane was visualized by an
enzymatic method and diaminobenzidine staining. No other stains were
used for the section shown in Figure 3D
. High contrast can be
observed in the center, at the bottom, and at the 2 shoulders of the
core of the plaque. The thickened intima next to the core of the plaque
had also accumulated cholesterol. The high concentrations
of cholesterol at these locations correspond with the high
relative amounts of total cholesterol found with Raman
spectroscopy (in Figure 3C
-2, solid arrowhead). A fine line can
be observed around the atheromatous core, indicating
the border of calcific deposits before decalcification (Figure 3D
, open arrowheads). This line suggests that calcific deposits
were located throughout the core of the plaque. These observations are
in agreement with the size of the calcification detected with IVUS and
with the high amounts of CS found with Raman spectroscopy.
Figure 4
illustrates for 4
arterial samples how the calcification-positive areas over
360° that were detected by IVUS compare with the parts of the
arterial wall containing >6% CS that were determined by
Raman spectroscopy.18 In general, the arch that contains
>6% CS is slightly larger than the arch that is found positive for
calcification with IVUS. In addition, Raman spectroscopic techniques
can detect and quantify the presence of cholesterol in the
arterial wall. As shown in Figure 4
, the
cholesterol in these arterial samples is found
to be located at the border of calcified areas extending into the
noncalcified areas.
|
The radial segments that were IVUS calcification positive (n=2) were
found to have high amounts of CS by Raman spectroscopy (Figure 5
). In the radial segments that were IVUS
calcification negative (n=80), the relative amounts of CS were found to
be low. With IVUS considered to be the standard in this comparison,
sensitivity and specificity values for detecting calcifications can be
determined with Raman spectroscopy by calculating the CS values. A
receiver operating characteristic curve analysis accounting for
the association between segments of the same sample25
shows that the sensitivity for detecting IVUS calcification-positive
areas with Raman spectroscopy equals the specificity (83%) at a CS
value of 7%. Thus, it appears that the CS deposits must have a
relative weight of >7% to be detected accurately with IVUS.
|
| Discussion |
|---|
|
|
|---|
The arterial segments that were found to be calcified by IVUS correlated closely with the location of high amounts of CS detected by Raman spectroscopy. In addition, cholesterol deposits could be detected and quantified by Raman spectroscopy, but they could not be located accurately by IVUS. IVUS can accurately detect the presence of CS deposits >0.25 mm but lacks the ability to detect the presence of lipid pools.5 7 Not only can Raman spectroscopy identify the major chemical components of the coronary arterial wall, such as total cholesterol, CS, triglycerides+phospholipids, and ß-carotene, but it can also quantify these amounts.17 24 26 The detection and quantification of cholesterol may be important in clinical practice, in view of the fact that a number of recent studies have demonstrated that plaque rupture occurs primarily in lipid-rich plaques covered with a fragile fibrous cap.10 27 28 29 An important goal in our future Raman spectroscopyassisted IVUS studies is to detect these rupture-prone atherosclerotic plaques in coronary arteries.
When IVUS images and quantitative chemical information obtained with
Raman spectroscopy of the same specimen are compared, possible sampling
errors must be taken into account. IVUS images collected in the
present study were obtained from arterial slices with a
thickness of 350 to 500 µm. The IVUS information from this
arterial volume is depicted 2-dimensionally and compared
with the quantitative information about the chemical composition at a
number of spots in this volume. The measuring volume of the Raman
spectroscopic method was
10 times smaller than that of the IVUS
measurements, in view of the fact that the diameter of the laser spot
at the arterial surface was
25 µm. (Deeper in the
tissue, the diameter of the cone of laser light traveling through the
tissue will become larger because of the diffuse light scattering but
not substantially larger than the illumination spot size.) Areas that
appear calcification positive on IVUS images may have contained small
areas free of CS, which may have been examined with Raman spectroscopy.
Areas that appear calcification negative on IVUS images may have
contained small calcifications that are detected with Raman
spectroscopy. Some of the mismatches between the IVUS and Raman
spectroscopy data may have originated from this disparity in examined
volume. Another source for mismatches between the IVUS and Raman
spectroscopy data may be caused by the attenuation of the Raman signal
from calcified deposits located deeply within the tissue. Recently, we
completed a study involving the attenuation of Raman scattering from
cholesterol at various depths in atherosclerotic plaques in
vitro.24 A Raman signal attenuation curve was made with
human intima/media coronary tissue that showed that
300
µm of tissue attenuates cholesterol signals by 50%. We
assume that this type of tissue attenuates scattering light from
calcified tissue in approximately the same manner as from
cholesterol deposits. This could have resulted in a
measured CS content <7%, whereas IVUS detected these segments as
calcification positive.
Other researchers who conducted in vitro IVUS studies used arterial samples that were submerged in saline or filled with agar-agar solution,30 or the arterial samples were perfused with saline at 100 mm Hg31 to mimic the physiological shape and size of the artery. In the present study, arterial samples were submerged in saline and were not perfused at 100 mm Hg during IVUS measurements because this could have increased the diameter of the artery asymmetrically. Comparison with Raman spectroscopic examination and histology, conducted on flattened nonperfused arterial tissue, would then have become difficult.
The histological section that was stained
specifically for cholesterol (see Figure 3D
) shows
that the thickened intima contains cholesterol. However,
these sections did not contain cholesterol clefts, which
are indicative of the presence of cholesterol crystals.
This clearly demonstrates the need for specific
cholesterol-staining techniques23 to visualize
the cholesterol content of an artery. Before it was
sectioned, the arterial sample in Figure 3
was
decalcified to avoid cutting artifacts, but the CS deposit residue is
still visible in the atheromatous core of the plaque
after hematoxylin and eosin staining.
Clinical intravascular use of Raman spectroscopy requires the use of optical fibers. With sensitive laboratory spectroscopic equipment, high-quality spectra can be collected in less than a second, and with the use of optical fiber catheters, most spectral features are visible in spectra collected in only a few seconds.15 20 Optical fibers are currently being optimized for the collection of high-quality intravascular Raman spectra in vivo.32 Current efforts are aimed at the simultaneous acquisition of IVUS images and Raman spectra through an integrated IVUS/Raman spectroscopic sideways-looking catheter. To create a blood-free environment during Raman measurements, such a catheter could be equipped with a proximal port for saline flush or an inflated balloon mounted at the catheter tip. IVUS may then serve as a guiding tool for the intravascular use of Raman spectroscopy in vivo, enabling in vivo histopathology and monitoring the chemical composition of an artery after medical therapeutic intervention, percutaneous transluminal coronary angioplasty, or coronary atherectomy.
Our recent study24 involving the attenuation of
Raman scattering from cholesterol at various depths in real
plaques in vitro (
300 µm of tissue attenuates
cholesterol signals by 50%) implies that Raman
spectroscopy can detect subsurface structures that are >1 mm
beneath an arterial surface. Therefore, Raman spectroscopy
should be capable of detecting atherosclerotic deposits under thick
fibrous caps.16 24 33
This information, combined with tomographic information about the architecture of the artery provided by IVUS, may be used to calculate the concentrations of the major chemical components at various depths. If serial measurements with a motorized pull-back system are collected, detailed chemical mappings of lesions at interest could be made. Such information may provide improved risk stratification, a means to guide therapeutic intervention (for instance, assessment of the need for stent implantation even at moderately stenosed coronary sites), and an instrument to monitor the effects of medical therapy in the individual patient. Future studies will aim at exploiting the tomographic capabilities of IVUS to create detailed chemical mappings over the entire depth of the arterial wall.
In conclusion, the present study suggests that information about the chemical composition of an arterial wall obtained with Raman spectroscopic techniques and morphological information generated with IVUS may be a very useful combination. When catheter technology allows intravascular Raman spectroscopy in vivo, the combination with IVUS may allow the clinician to monitor the effects of lipid-lowering therapies and to identify lesions that are prone to rupture.
| Acknowledgments |
|---|
Received July 29, 1998; accepted August 6, 1999.
| References |
|---|
|
|
|---|
2. Nissen SE, Gurley JC, Booth DC, De Maria AN. Intravascular ultrasound of the coronary arteries: current applications and future directions. Am J Cardiol. 1992;69(suppl)18H29H.
3. Nissen SE, De Franco AC, Tuzco EM, Molitherno DJ. Coronary intravascular ultrasound: diagnostic and interventional applications. Coron Artery Dis. 1995;6:355367.[Medline] [Order article via Infotrieve]
4. Gussenhoven WJ, Essed CE, Frietman P, Mastik F, Lancee C, Slager C, Serruys P, Gerritsen P, Pieterman H, Bom N. Intravascular echographic assessment of vessel wall characteristics: a correlation with histology. Int J Card Imaging. 1989;4:105116.[Medline] [Order article via Infotrieve]
5. Peters RJG, Kok WEM, Havenith MG, Rijsterborgh H, van der Wal AC, Visser CA. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiogr. 1994;7:230241.[Medline] [Order article via Infotrieve]
6. Becker AE. Ultrasound imaging and atherogenesis. Int J Card Imaging. 1989;4:99104.[Medline] [Order article via Infotrieve]
7. Benkeser PJ, Churchwell AL, Lee C, Abouelnasr D. Resolution limitations in intravascular ultrasound imaging. J Am Soc Echocardiogr. 1993;6:158165.[Medline] [Order article via Infotrieve]
8.
Small DM. George Lyman Duff memorial lecture:
progression and regression of atherosclerotic lesions: insights from
lipid physical biochemistry.
Arteriosclerosis. 1988;8:103129.
9. Dzau V. Pathobiology of atherosclerosis and plaque composition. Am Heart J. 1994;128:13001304.[Medline] [Order article via Infotrieve]
10.
Libby P. Molecular bases of the acute
coronary syndromes. Circulation. 1995;91:28442850.
11. Raman CV, Krishnan KS. A new type of secondary radiation. Nature. 1928;121:501502.
12. Koningstein JA. Introduction to the Theory of the Raman Effect. Dordrecht, the Netherlands: D Reidel Publishing Co; 1971.
13. Tu AT. Raman Spectroscopy in Biology. New York, NY: John Wiley & Sons Inc; 1982.
14. Spiro TG. Biological Applications of Raman Spectroscopy. Vol 13. New York, NY: John Wiley & Sons Inc; 19871988.
15. Brennan JFB III, Wang Y, Dasari RR, Feld MS. Near-infrared Raman spectrometer systems for human tissue studies. Appl Spectrosc. 1997;51:201208.
16.
Baraga JJ, Feld MS, Rava RP. In situ optical
histochemistry of human artery using near infrared Fourier transform
Raman spectroscopy. Proc Natl Acad Sci U S A. 1992;89:34733477.
17.
Brennan JF III, Römer TJ, Lees RS, Tercyak
AM, Kramer JR Jr, Feld MS. Determination of human coronary
artery composition by Raman spectroscopy. Circulation. 1997;96:99105.
18.
Römer TJ, Brennan JF III, Fitzmaurice M,
Feldstein ML, Deinum G, Myles JL, Kramer JR, Lees RS, Feld MS.
Histopathology of human coronary
atherosclerosis by quantifying its chemical composition
with Raman spectroscopy. Circulation. 1998;97:878885.
19. Kramer JR, Brennan JF III, Römer TJ, Wang Y, Dasari RR, Feld MS. Spectral diagnosis of human coronary artery disease: a clinical system for real time analysis. Proc BIOS/SPIE. 1995;2305:376382.
20. Puppels GJ, Van Aken T, Wolthuis R, Caspers PJ, Bakker Schut TC, Bruining HA, Römer TJ, Buschman HPJ, Wach ML, Marple ET. In vivo tissue characterization by Raman spectroscopy. Presented at: Proceedings of the SPIE International Symposium on Biomedical Optics, San Jose, CA. 1998;3257:7883.
21. Lewis IR, Griffiths PR. Raman spectrometry with fiber-optic sampling. Appl Spectrosc. 1996;50:12A30A.
22.
Jukema JW, Zwinderman AH, van Boven AJ, Reiber
JHC, van der Laarse JHC, Lie KI, Bruschke AVG. Evidence for a
synergistic effect of calcium channel blockers with lipid-lowering
therapy in retarding progression of coronary
atherosclerosis in symptomatic patients
with normal to moderately raised cholesterol levels: the
REGRESS Study Group. Arterioscler Thromb Vasc Biol. 1996;16:425430.
23. Emeis JJ, Van Gent CM, Van Sabben CM. An enzymatic method for the histochemical localization of free and esterified cholesterol separately. Histochem J. 1977;9:197204.[Medline] [Order article via Infotrieve]
24. Römer TJ, Brennan JF III, Bakker Schut TC, Wolthuis R, Van den Hoogen RCM, Jemeis JJ, Van der Laarse A, Bruschke AVG, Puppels G. Raman spectroscopy for quantifying cholesterol in intact coronary artery wall. Atherosclerosis. 1998;141:117124.[Medline] [Order article via Infotrieve]
25. Toledano AY, Gatsonis C. Ordinal regression methodology for ROC curves derived from correlated data. Stat Med. 1996;15:18071826.[Medline] [Order article via Infotrieve]
26. Manoharan R, Baraga JJ, Feld MS, Rava RP. Quantitative histochemical analysis of human artery using Raman spectroscopy. J Photochem Photobiol B. 1992;16:211233.[Medline] [Order article via Infotrieve]
27. Badimon L, Badimon JJ, Gold HK, Fuster V. Coronary atherosclerosis: morphology and characteristics to identify by evolving imaging technology. Am J Card Imaging. 1992;6:278288.
28. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the development of myocardial infarction. N Engl J Med. 1992;326:242250.[Medline] [Order article via Infotrieve]
29.
Guyton JR, Klemp KF. Development of the
lipid-rich core in human atherosclerosis.
Arterioscler Thromb Vasc Biol. 1996;16:411.
30. Wenguang L, Gussenhoven WJ, Zhong Y. Validation of quantitative analysis of intravascular ultrasound images. Int J Card Imaging. 1991;6:247253.[Medline] [Order article via Infotrieve]
31. Maheswaran B, Leung CY, Gutfinger DE. Intravascular ultrasound appearance of normal and mildly diseased coronary arteries. Am Heart J. 1995;130:976986.[Medline] [Order article via Infotrieve]
32. Buschman HP, Römer TJ, Puppels GJ, Van der Laarse A, Bruschke AVG. Human coronary atherosclerosis studied in vitro by transluminal Raman spectroscopy. Presented at: 2nd European Conference on Cardiac PET Imaging; May 1998; Groningen, the Netherlands.
33. Tracy RE, Kissling GE. Age and fibroplasia as preconditions for atheronecrosis in human coronary arteries. Arch Pathol Lab Med. 1987;111:957963.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
S. Waxman, F. Ishibashi, and J. E. Muller Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events Circulation, November 28, 2006; 114(22): 2390 - 2411. [Full Text] [PDF] |
||||
![]() |
J. T. Willerson and P. M. Ridker Inflammation as a Cardiovascular Risk Factor Circulation, June 1, 2004; 109(21_suppl_1): II-2 - II-10. [Abstract] [Full Text] [PDF] |
||||
![]() |
S W E van de Poll, K Kastelijn, T C B. Schut, C Strijder, G Pasterkamp, G J Puppels, and A van der Laarse On-line detection of cholesterol and calcification by catheter based Raman spectroscopy in human atherosclerotic plaque ex vivo Heart, September 1, 2003; 89(9): 1078 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. MacNeill, H. C. Lowe, M. Takano, V. Fuster, and I.-K. Jang Intravascular Modalities for Detection of Vulnerable Plaque: Current Status Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): 1333 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.L. de Korte, S.G. Carlier, F. Mastik, M.M. Doyley, A.F.W. van der Steen, P.W. Serruys, and N. Bom Morphological and mechanical information of coronary arteries obtained with intravascular elastography. Feasibility study in vivo Eur. Heart J., March 1, 2002; 23(5): 405 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W.E. van de Poll, T. J. Romer, O. L. Volger, D. J.M. Delsing, T. C. Bakker Schut, H. M.G. Princen, L. M. Havekes, J. W. Jukema, A. van der Laarse, and G. J. Puppels Raman Spectroscopic Evaluation of the Effects of Diet and Lipid-Lowering Therapy on Atherosclerotic Plaque Development in Mice Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1630 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Fayad and V. Fuster Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque Circ. Res., August 17, 2001; 89(4): 305 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Moreno, R. A. Lodder, K. R. Purushothaman, W. E. Charash, W. N. O'Connor, and J. E. Muller Detection of Lipid Pool, Thin Fibrous Cap, and Inflammatory Cells in Human Aortic Atherosclerotic Plaques by Near-Infrared Spectroscopy Circulation, February 26, 2002; 105(8): 923 - 927. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |